As we have informed here, the private equity firm Argos Wityu has acquisted a majority stake in Norline, a leading provider of outsourcing services in the heating, ventilation, air conditioning and plumbing sector in Switzerland. Norline’s founder Hanspeter Acklin will remain a minority shareholder, along with further managers of the company, and will continue to […]
Oculis Holding, a global biopharmaceutical company, purposefully driven to save sight and improve eye care, listed its shares on Nasdaq after successfully closing the business combination between European Biotech Acquisition Corp. (“EBAC”). At closing, Oculis
CODE41, a community-centric Swiss watchmaking company, has increased its share capital by issuing participation certificates in the form of ledger-based securities, thanks to the tokenisation technology of Taurus and the opensource smart contract published by
The European Investment Bank (EIB) and GeNeuro, a French biopharmaceutical company, has entered through its R&D subsidiary, GeNeuro Innovation, into a financing agreement for a total amount of up to EUR 25 million. The
Niederer Kraft Frey has advised Bearmind as Swiss counsel on its seed financing round led by HH Equity Partners II. The EPFL spinoff has secured CHF 1.3 million in the seed round that also included participation
The Swiss startup AICA has closed a CHF 1.2 million financing round to give robots a sense of touch and enable autonomous learning. Niederer Kraft Frey advised AICA as Swiss counsel on its seed financing round
Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system disorders, successfully closed an oversubscribed Series B financing round, raising CHF 103 mio (approx. USD 112 mio). The round was co-led by the European healthcare focused
Santhera Pharmaceuticals Holding announced a private placement of shares and an amendment of its existing financing with funds managed by Highbridge Capital Management to provide up to CHF 22.2 million in aggregate, subject to certain milestones
The German life science and medtech private equity firm SHS Capital has made a EUR 10 million investment in Simulands, a Swiss manufacturer of simulation devices for medical training of cardiovascular interventions. The investment aims to
The Eastman Group, an internationally operating manufacturer of musical instruments, acquired the music manufacturing business from WILLSON Band Instruments Switzerland. Willson is a Swiss manufacturer of handmade, high-quality musical instruments. Willson has been a leader
